Barbra Keck
Finanzdirektor/CFO bei SMARTKEM, INC.
Vermögen: 750 $ am 30.04.2024
Aktive Positionen von Barbra Keck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SMARTKEM, INC. | Finanzdirektor/CFO | 14.12.2022 | - |
| Direktor/Vorstandsmitglied | 23.02.2021 | 21.11.2023 | |
| Independent Dir/Board Member | 23.02.2021 | 14.12.2022 | |
SmartKem Ltd.
 SmartKem Ltd. Industrial SpecialtiesProcess Industries SmartKem Ltd. engages in the design, development, industrialization, and technology transfer of solution-deposited organic semiconductors for transistor backplanes. The company was founded by Steve Paul Kelly in 2009 and is headquartered in St. Asaph, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Barbra Keck
Ehemalige bekannte Positionen von Barbra Keck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Finanzdirektor/CFO | 01.01.2009 | 31.05.2020 |
| DELCATH SYSTEMS, INC. | Comptroller/Controller/Auditor | 01.01.2009 | 01.05.2020 |
| Finanzdirektor/CFO | 21.02.2017 | 01.05.2020 | |
| Unternehmenssekretär | 21.02.2017 | 01.05.2020 | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.08.2008 | 04.12.2008 |
| Zicklin School of Business | Corporate Officer/Principal | 01.06.2006 | 01.08.2008 |
| Young Audiences New York | Public Communications Contact | 01.09.2005 | 01.05.2006 |
| University of Dayton | Corporate Officer/Principal | 01.01.1999 | 01.01.2005 |
| Muse Machine | Corporate Officer/Principal | 01.01.2002 | 01.01.2003 |
| ░░░░ ░░░░░░░ ░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Barbra Keck
| University of Dayton | Undergraduate Degree |
| Baruch College | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 10 |
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 5 |
| Director of Finance/CFO | 3 |
| Director/Board Member | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DELCATH SYSTEMS, INC. | Health Technology |
| SMARTKEM, INC. | Electronic Technology |
| Private Unternehmen | 6 |
|---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Bach Society of Dayton, Inc.
 Bach Society of Dayton, Inc. Miscellaneous Commercial ServicesCommercial Services Bach Society of Dayton, Inc. performs and conducts singing shows. The company was founded in 2002 and is headquartered in Dayton, OH. | Commercial Services |
SmartKem Ltd.
SmartKem Ltd. Industrial SpecialtiesProcess Industries SmartKem Ltd. engages in the design, development, industrialization, and technology transfer of solution-deposited organic semiconductors for transistor backplanes. The company was founded by Steve Paul Kelly in 2009 and is headquartered in St. Asaph, the United Kingdom. | Process Industries |
| Young Audiences New York | |
| Muse Machine | |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Barbra Keck
- Erfahrung
